 PHILADELPHIA, Nov. 23, 2020 GLOBE NEWSWIRE -- Passage Bio, Inc. Nasdaq: PASG, a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system disorders, today announced that Bruce Goldsmith, Ph.D., chief executive officer of Passage Bio, will participate in a fireside chat at the virtual Piper Sandler 32nd Annual Healthcare Conference, taking place December 1 3, 2020. 